Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Gatehouse Bio logo — A TechBio company utilizing AI to decode the landscape of sm...

Gatehouse Bio

A TechBio company utilizing AI to decode the landscape of small RNAs (sRNAs) and design precision oligonucleotides

Founded 2020 United States Natick, United States 11 employees Convertible Note Total: $7.95M Biotechnology

General Information

Company Name Gatehouse Bio
Founded Year 2020
Location United States Natick, United States
Employees 11
Industries Biotechnology
Funding Stage Convertible Note
Social

BounceWatch is an independent company data service, not affiliated with Gatehouse Bio. To contact Gatehouse Bio, visit gatehousebio.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Gatehouse Bio compare?

A PDF of Gatehouse Bio and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Gatehouse Bio soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Gatehouse Bio

Gatehouse Bio is a groundbreaking TechBio company harnessing the power of artificial intelligence to decipher the complex realm of small RNAs (sRNAs) and craft precision oligonucleotides. Founded in 2018 and headquartered in the United States, the company is dedicated to decoding sRNA isoforms for the development of biomarker-guided precision oligonucleotide therapeutics. This is achieved through their innovative AI-powered Code-Breaker™ Platform, which enables the identification and characterization of disease-associated isoforms and the digital design of therapeutics to counteract their effects. The last known investment for Gatehouse Bio was a Convertible Note funding round on 20 September 2023. Notable investors in this round included SOSV and indiebio, signifying the growing interest in the company's innovative approach within the Biotechnology sector. Gatehouse Bio's compelling focus on utilizing AI to unravel the mysteries of sRNAs and design precise therapeutics positions it as a promising player in the biotech landscape, offering potential for significant impact and growth in the future.

Business keywords: TechBio, small RNA, sRNA, oligonucleotides, RNA therapeutics, in silico, digital drug design, precision medicines

Funding Rounds & Investors (7)

View All
Funding Stage Amount Investors Lead Investors Date
Convertible Note Undisclosed 2
SOSV indiebio
SOSV, indiebio
20 Sep 2023
Seed Round Undisclosed 2
SOSV indiebio
SOSV, indiebio
30 Sep 2022
Convertible Note Undisclosed 2
SOSV indiebio
SOSV, indiebio
23 Jun 2022
Seed Round Undisclosed 2
SOSV indiebio
SOSV, indiebio
08 Dec 2021
Series A $5.45M 2
SOSV indiebio
SOSV, indiebio
15 Jan 2021
Seed Round $2.50M 1
Front Row Fund
Front Row Fund
07 Jan 2021
Seed Round Undisclosed 2
SOSV indiebio
SOSV, indiebio
24 Dec 2020

Gatehouse Bio Alternatives & Competitors

View All Alternatives
Gatehouse Bio vs
HAYA Therapeutics
HAYA Therapeutics Switzerland

Programmable Therapeutics for Causal Biology - Science Guides Us. The Genome Powers Us. Patients Gr...

68 employees
Biopharma, Biotechnology
Gatehouse Bio vs
Wave Life Sciences
Wave Life Sciences United States

Unlocking the broad potential of RNA medicines to transform human health

Post-IPO Equity
379 employees
Biotechnology, Health Care
Compare Gatehouse Bio vs Wave Life Sciences
Gatehouse Bio vs
Rona Therapeutics
Rona Therapeutics China

Empower Great People To Do Great Things

Series A
10 employees
Biotechnology, Health Care
Also compare with: Gatehouse Bio vs Odyssey Therapeutics Odyssey Therapeutics View all alternatives

FAQ About Gatehouse Bio

A TechBio company utilizing AI to decode the landscape of small RNAs (sRNAs) and design precision oligonucleotides
Gatehouse Bio was founded in 2020.
Gatehouse Bio is headquartered in Natick, United States.
Gatehouse Bio operates in Biotechnology. Its work centres on TechBio, small RNA, sRNA and oligonucleotides.
Gatehouse Bio has approximately 11 employees.
Gatehouse Bio has completed 7 funding rounds, raising a total of $7.95M. The latest funding stage is Convertible Note.
Top alternatives and competitors to Gatehouse Bio include HAYA Therapeutics, Wave Life Sciences, Rona Therapeutics, Bound Therapeutics, Expansion Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Gatehouse Bio and HAYA Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Gatehouse Bio, https://bouncewatch.com/company/gatehouse-bio, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes